Glioblastoma, bone sarcoma, and liver cancer: tough battles rage on for some tumors

Article Type

Changed

Wed, 05/26/2021 - 13:57

Display Headline

Author(s)

Improvements in our understanding of the molecular mechanisms of cancer combined with advances in genome sequencing have provided revolutionary new therapeutic options for several hard-to-treat tumors in recent decades. For other challenging tumor types these advancements have served only to highlight their significant complexity and, despite the development of novel treatments, there has been limited improvement in prognosis.

Click on the PDF icon at the top of this introduction to read the full article.

Article PDF

JCSO_April_2015_162_De_Lartigue.pdf

Issue

The Journal of Community and Supportive Oncology - 13(4)

Publications

The Journal of Community and Supportive Oncology

MDedge Hematology and Oncology

Topics

Gastroenterology

Sarcoma & GIST

CNS/Brain Cancer

Gastrointestinal Cancer

Page Number

162-166

Legacy Keywords

Glioblastoma, bone sarcoma, liver cancer, GBM, VEGF, VEGFR,
osteosarcoma, chondrosarcoma, CS, Ewing sarcoma, ES, hepatocellular carcinoma, HCC

Sections

Author(s)

Author(s)

Article PDF

JCSO_April_2015_162_De_Lartigue.pdf

Article PDF

JCSO_April_2015_162_De_Lartigue.pdf

Improvements in our understanding of the molecular mechanisms of cancer combined with advances in genome sequencing have provided revolutionary new therapeutic options for several hard-to-treat tumors in recent decades. For other challenging tumor types these advancements have served only to highlight their significant complexity and, despite the development of novel treatments, there has been limited improvement in prognosis.

Click on the PDF icon at the top of this introduction to read the full article.

Improvements in our understanding of the molecular mechanisms of cancer combined with advances in genome sequencing have provided revolutionary new therapeutic options for several hard-to-treat tumors in recent decades. For other challenging tumor types these advancements have served only to highlight their significant complexity and, despite the development of novel treatments, there has been limited improvement in prognosis.

Click on the PDF icon at the top of this introduction to read the full article.

Issue

The Journal of Community and Supportive Oncology - 13(4)

Issue

The Journal of Community and Supportive Oncology - 13(4)

Page Number

162-166

Page Number

162-166

Publications

The Journal of Community and Supportive Oncology

MDedge Hematology and Oncology